TaiAn Technologies Corporation
TaiAn Technologies Corporation is a technology advisory company that specializes in commercializing intellectual properties in the life sciences. Our team comprised of numerous biomedical experts that work closely with investment professionals to support up-and-coming life science technologies. Most importantly, we are entrusted by our shareholders to explore technology platforms in the life sciences arena, to build upon the novel technologies, and to transform them into viable business opportunities supporting existing or creating new entities. Our shareholders comprised of Development Fund of the Executive Yuan of Taiwan as well as numerous conglomerates that are recognized in Taiwan and internationally well known. Leveraging our shareholders/ partners' resources and our strong management team, our multiplex services create synergies with Taiwanese corporations and add significant value to your company.
Past deals in Taiwan
Aprinoia Therapeutics
Series B in 2018
Aprinoia Therapeutics Inc. is a clinical-stage biotechnology company focused on the research, development, and manufacturing of innovative diagnostic tools for the detection of neurological diseases. Established in 2015 and headquartered in Taipei, Taiwan, with additional locations in China and Japan, the company specializes in advanced imaging techniques, notably the 18F-PM-PBB3 tau positron-emission tomography (PET) imaging tracer. This tracer aids in diagnosing tauopathies and supports the development of therapeutic programs for conditions such as Alzheimer's disease, Parkinson's disease, and dementia. Additionally, Aprinoia manufactures an alpha-synuclein PET imaging tracer. The company's mission is to enhance brain health and improve clinical outcomes for patients suffering from various neurodegenerative diseases by leveraging precision medicine to target harmful protein aggregates involved in these conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.